Newborn screening for sickle cell disease: A 1988-2003 Quebec experience

Paediatrics and Child Health

Volumn 11, Issue 4, 2006, Pages 223-227

  Robitaille, Nancy ^a   Delvin, Edgard E ^a   Hume, Heather A ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

Neonatal screening; Sickle cell disease

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ARTICLE; BETA THALASSEMIA; CANADA; CONTROLLED STUDY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFANT; ISOELECTRIC FOCUSING; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PHENOTYPE; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; UMBILICAL CORD BLOOD;

EID: 33744821384     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/11.4.223     Document Type: Article

References (32)

1. Whitten CF, Whitten-Shurney W. Sickle cell. Clin Perinatol 2001;28:435-48.
2. Elghetany MT, Davey FR. Erythrocytic disorders. In: Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods, 19th edn. Philadelphia: WB Saunders Company, 1996:617-63.
3. Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program. J Pediatr Hematol Oncol 1996;18:36-41.
4. Galactéros F. [Neonatal screening for sickle cell anemia in metropolitan France. For the group for neonatal screening of sickle cell anemia of the French Association for Screening and Prevention of Infant Handicaps (AFDPHE)]. Pathol Biol (Paris) 1999;47:13-8.
5. Consensus conference. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA 1987;258:1205-9.
6. Ali M, Lafferty J. The clinical significance of hemoglobinopathies in the Hamilton region: A twenty-year review. Clin Invest Med 1992;15:401-5.
7. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
8. Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 1995;86:776-83.
9. Powars DR. Natural history of sickle cell disease - The first ten years. Semin Hematol 1975;12:267-85.
10. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics 1989;84:500-8.
11. McIntosh S, Rooks Y, Ritchey AK, Pearson HA. Fever in young children with sickle cell disease. J Pediatr 1980;96:199-204.
12. Overturf GD, Powars D, Baraff LJ. Bacterial meningitis and septicemia in sickle cell disease. Am J Dis Child 1977;131:784-7.
13. Powars D, Overturf G, Weiss J, Lee S, Chan L. Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival. JAMA 1981;245:1839-42.
14. Pearson HA, McIntosh S, Ritchey AK, Lobel JS, Rooks Y, Johnston D. Developmental aspects of splenic function in sickle cell diseases. Blood 1979;53:358-65.
15. Rogers DW, Clarke JM, Cupidore L, Ramlal AM, Sparke BR, Serjeant GR. Early deaths in Jamaican children with sickle cell disease. Br Med J 1978;1:1515-6.
16. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314:1593-9.
17. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: Effect on mortality. Pediatrics 1988;81:749-55.
18. Grover R. Newborn screening for sickle cell disease and other hemoglobinopathies. Newborn screening in New York City. Pediatrics 1989;83:819-22.
19. Centers for Disease Control and Prevention (CDC). Mortality among children with sickle cell disease identified by newborn screening during 1990-1994 - California, Illinois, and New York. MMWR Morb Mortal Wkly Rep 1998;47:169-72.
20. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103:4023-7.
21. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: Lessons from a cohort study. BMJ 1995;311:1600-2.
22. Section on Hematology/Oncology, Committee on Genetics; American Academy of Pediatrics. Health supervision for children with sickle cell disease. Pediatrics 2002;109:526-35.
23. Yorke D, Mitchell J, Clow C, et al. Newborn screening for sickle cell and other hemoglobinopathies: A Canadian pilot study. Clin Invest Med 1992;15:376-83.
24. Lorey F, Cunningham G, Shafer F, Lubin B, Vichinsky E. Universal screening for hemoglobinopathies using high-performance liquid chromatography: Clinical results of 2.2 million screens. Eur J Hum Genet 1994;2:262-71.
25. Schneider RG. Laboratory identification of hemoglobin variants in the newborn. In: Carter TP, Wiley AM, eds. Genetic Disease - Screening and Management. New York: Alan R Liss, 1986:137.
26. Eastman JW, Wong R, Liao CL, Morales DR. Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies. Clin Chem 1996;42:704-10.
27. Serving the family from birth to the medical home. A report from the Newborn Screening Task Force convened in Washington DC, May 10-11, 1999. Pediatrics 2000;106:383-427.
28. Harris MS, Eckman JR. Georgia's experience with newborn screening: 1981 to 1985. Pediatrics 1989;83:858-60.
29. Panepinto JA, Magid D, Rewers MJ, Lane PA. Universal versus targeted screening of infants for sickle cell disease: A cost-effectiveness analysis. J Pediatr 2000;136:201-8.
30. Sprinkle RH, Hynes DM, Konrad TR. Is universal neonatal hemoglobinopathy screening cost-effective? Arch Pediatr Adolesc Med 1994;148:461-9.
31. Statistics Canada, 〈http://www40.statcan.ca/101/cst01/index. htm〉 (Version current at April 5, 2006).
32. Charbonneau M, Laberge C, Scriver CR, Dussault JH, Lemieux B, Melançon S. The Quebec Network of Genetic Medicine. Can J Public Health 1987;78:79-83.